JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solans, R.
Right arrow Articles by Vilardell, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solans, R.
Right arrow Articles by Vilardell, M.

Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy

Roser Solans, Josep-Angel Bosch, Pere Galofré, Francesc Porta, José Roselló, Albert Selva-O’Callagan and Miquel Vilardell

Departments of Internal Medicine, Nuclear Medicine, and Preventive Medicine and Epidemiology, Vall d’Hebron General Teaching Hospital, Barcelona, Spain



View larger version (98K):

[in a new window]
  		FIGURE 1. Salivary gland scintigraphy stages depend on salivary gland uptake and excretion: stage 1, normal uptake and excretion; stage 2, mild to moderate dysfunction; stage 3, moderate to severe dysfunction; and stage 4, severe dysfunction.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.